Status:
WITHDRAWN
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Lead Sponsor:
George Washington University
Collaborating Sponsors:
Pfizer
Conditions:
Psychosis
Agitation
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of ...
Eligibility Criteria
Inclusion
- Acutely agitated
- Requires chemical sedation
Exclusion
- Physician preference for a specific chemical sedative
- Known allergy to any study medications
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00786318
Start Date
September 1 2008
End Date
July 1 2011
Last Update
September 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The George Washington University Medical Center, Dept of Emergency Medicine
Washington D.C., District of Columbia, United States, 20037